Invitae is a rapidly growing, technology-driven company. Our mission is to empower doctors and patients to use genetic information to make informed medical decisions at all life stages. Our Medical Affairs team plays a key role in driving expansion of our genomic platform capabilities.
Serve as expert on the current state and future prospects for solid tumor somatic mutation testing on the management of patients with cancer.
Consult with the R&D team on the content and development of Invitae's V1 somatic testing panel
Remain up-to-date on advances in the field of somatic testing and consult on procedures to ensure accurate revisions/upgrades of the panel after V1 is launched
Consult with the development team on the design and layout of Invitae's somatic testing panel report focusing on making the report accessible and compelling for providers using the test
Consult with the VI team on how the somatic report and germline report inform each other and how the complementary combination of the two tests is best reflected in the report.
Participate as outward facing Medical Affairs expert representing Invitae at scientific and medical meetings, with CMS and third party payers, and with the FDA
Participate as outward facing Medical Affairs expert in developing and executing collaborations and publications that utilize and showcase the Invitae somatic panel
Help develop and signoff on assay validation plan
Participate in somatic mutation oncology report sign out
ABP Molecular Pathologist
MGP or ABMGG certification preferred*
Experience with NGS sequencing of tumor specimens
Excellent verbal and written communication skills
Previous experience in clinical research involving somatic tumor testing preferred
At Invitae, we value diversity and provide equal employment opportunities (EEO) to all employees and applicants without regard to race, color, religion, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status. We will consider for employment qualified applicants with criminal histories in a manner consistent with the requirements of the San Francisco Fair Chance Ordinance.